ITUS' noninvasive, blood-based Cchek test successfully diagnoses liver cancer: 3 notes

Cchek early cancer detection technology has successfully been used to identify the presence of liver cancer.

Here's what you need to know:

1. Cchek is developed by ITUS, a Los Angeles-based biotechnology development and acquisition company. Cchek is a noninvasive blood test, which detects immune system cells associated with tumors.

2. ITUS has successfully used Cchek to detect liver cancer in patients who were previously diagnosed using traditional methods, like surgical biopsies.

3. The company has also seen successful results when using Cchek to detect breast cancer, colorectal cancer, lung cancer, ovarian cancer and melanoma.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast